Page last updated: 2024-10-30

losartan and Leriche Syndrome

losartan has been researched along with Leriche Syndrome in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Leriche Syndrome: A condition caused by occlusion of terminal aorta, the primary branches of the ABDOMINAL AORTA, as in aortoiliac obstruction. Leriche syndrome usually occurs in males and is characterized by IMPOTENCE, absence of a pulse in the femoral arteries, weakness and numbness in the lower back, buttocks, hips, and lower limbs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poli, D1
Pecci, A1
Noris, P1
Gensini, GF1

Other Studies

1 other study available for losartan and Leriche Syndrome

ArticleYear
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia.
    Internal and emergency medicine, 2006, Volume: 1, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Antihypertensive Agents; Drug The

2006